The race to find a more effective and non-evasive, injection-free therapy for patients with Type 1 diabetes involves many players. The remaining question is not when, but who is going to win: the tortoise or the hare? The tortoise represents biological replacement-based treatments or protection of beta insulin producing cells. The research community is investigating